Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
34.33
-0.06 (-0.17%)
Nov 18, 2026, 1:25 PM EST - Market open
LKFT Market Cap
LKFT has a market cap or net worth of $2.21 billion as of November 18, 2026. Its market cap has increased by 7.41% in one year.
Market Cap
2.21B
Enterprise Value
-245.25M
1-Year Change
7.41%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since May 14, 2015, LKFT's market cap has increased from $1.86B to $2.21B, an increase of 18.87%. That is a compound annual growth rate of 1.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 2.27B | 5.17% |
| Dec 31, 2025 | 2.15B | 18.91% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
| May 14, 2015 | 1.86B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 2.36B |
| NewAmsterdam Pharma Company | 2.33B |
| Pharvaris | 2.27B |
| Celldex Therapeutics | 2.20B |
| Palvella Therapeutics | 2.11B |
| Aurinia Pharmaceuticals | 2.06B |
| Beam Therapeutics | 2.06B |
| Immunome | 2.03B |